263282 comments

• 
  identity verification requirements Freitag, 06 Dezember 2024 07:09 Comment Link

  Your consumers expect a one-click experience.
• 
  Bookmarks Freitag, 06 Dezember 2024 07:08 Comment Link

  It's easy to get a business electricity quote today.
• 
  Bookmarks Freitag, 06 Dezember 2024 07:07 Comment Link

  The plan's average price is 17.4 cents per kWh.
• 
  iqos เครื่อง Freitag, 06 Dezember 2024 07:06 Comment Link

  PMI's US launch of flagship IQOS device needs FDA
  green light
  
  *
  
  Six health campaign groups wrote letter to FDA criticising PMI Say PMI misrepresented past FDA
  decisions on IQOS
  
  *
  
  PMI says it discusses its products in accordance with law
  
  *
  
  FDA acknowledges receiving campaigners' letter
  
  (Updates headline)
  
  By Emma Rumney
  
  LONDON, July 16 (Reuters) - Health campaigners have written to U.S.
  regulators accusing Philip Morris International of misrepresenting past regulatory decisions, seeking to disrupt the launch of its flagship
  heated tobacco device IQOS in the United States.
  
  The world's biggest tobacco company by market value has spent billions
  of dollars developing the product, which investors see as key to driving future growth.
  But it needs permission from the U.S. Food and
  Drug Administration to sell it in the world's second largest
  tobacco market by revenue.
  
  Six anti-tobacco and health groups, including the Campaign for
  Tobacco-Free Kids, the American Academy of Pediatrics and the
  American Lung Association, wrote to the FDA to oppose IQOS-related
  applications PMI has submitted to the agency.
  
  "PMI has repeatedly made misleading and deceptive statements wrongly suggesting that the FDA has found that IQOS reduces the risk of disease," the letter, dated June 27 and
  reviewed by Reuters, said.
  
  The campaign groups allege that PMI violated the FDA's orders by suggesting IQOS offered lower risks than cigarettes.
  Their letter cited four examples of such statements in the United States, the Philippines,
  Mexico and Kazakhstan.
  
  They also said in the letter that upcoming independent studies contradict PMI's findings about how many IQOS users completely
  switch to the device from cigarettes.
  
  Presentations on the studies from the International
  Tobacco Control Project (ITC) at Canada's University of Waterloo are attached to the
  letter as exhibits.
  
  They show the ITC found a far lower rate of IQOS users had quit smoking in Japan and Korea than estimates from PMI.
  
  
  These factors "directly bear on whether PMI should be permitted to market IQOS" in the
  United States, the campaigners' letter said.
  
  The contents of the letter have not been previously reported.
  
  
  Asked by Reuters to respond to the letter, a PMI spokesperson said the company was proud to discuss the FDA's conclusions on IQOS.
  
  
  The spokesperson did not initially address each example but said some of
  the language flagged by campaigners was, in the company's view,
  compatible with the FDA's orders. On Tuesday, the spokesperson added that this was true all of the language cited in the
  campaigners' letter.
  
  "Wherever we discuss our science and our products, we do so in accordance with all applicable laws," the spokesperson said.
  
  
  Reuters could not determine whether the campaigners' letter would change the FDA's approach to IQOS.
  The agency said it had received the letter and
  would respond directly to the senders. It did not comment further.
  
  
  Devices like IQOS heat up sticks of ground tobacco without burning them in an attempt to avoid the harmful chemicals released via combustion.
  
  The FDA first authorised PMI to sell an older version of
  IQOS in 2019. It subsequently authorised the company to market it as offering reduced exposure
  to harmful chemicals versus cigarettes for smokers who completely switch - known as an "exposure modification order".
  
  
  The FDA can also issue a "risk modification order", authorising a company to
  claim its product reduces the risk of tobacco-related harm and
  disease. But this is harder to prove, especially without long-term, epidemiological studies.
  
  
  
  The FDA rejected PMI's previous application to say its older IQOS device results in reduced health risks,
  saying there wasn't sufficient evidence to support
  this.
  
  PMI applied in 2023 to renew its existing exposure modification orders.
  
  Later that year, it also applied to sell and market a newer version of the IQOS device in the same way.
  The FDA has yet to decide on these applications.
  
  
  Marketing the product as having health benefits compared to traditional cigarettes could help
  PMI persuade consumers to switch as well as afford it tax benefits versus
  cigarettes in some U.S. states.
  
  PMI is preparing to sell an older IQOS device
  in four U.S. cities. However, it has said it will not pursue a
  full U.S. launch until the newer version of its
  device gets FDA authorisation.
  
  SWITCH RATES
  
  The campaign groups also cited preliminary data from ITC studies in Japan and Korea, saying it contradicted
  PMI's findings about how many IQOS users completely switch from cigarettes.
  
  
  The studies have been presented at academic conferences but have
  not yet been submitted for publication in a journal, ITC researchers told Reuters.
  As a result, study abstracts have been peer reviewed but the full findings have yet to
  go through that process.
  
  Japan is IQOS' largest market and the introduction of heated tobacco there coincided with an accelerated decline in cigarette sales.
  
  
  
  PMI estimates more than seven out of 10 of its registered IQOS customers globally have quit cigarettes.
  A 2023 PMI application to the FDA emphasised that the
  majority of IQOS users were using IQOS exclusively.
  
  However, the ITC's researchers put the percentage of all IQOS users that had quit smoking at just
  15% in Japan and 30% in Korea in 2021.
  
  Users most commonly used IQOS and cigarettes simultaneously, known as "dual use", often leading
  to an overall increase in tobacco consumption, the ITC researchers found.
  
  
  PMI pointed to a 2019 Japanese government health survey, where 75% of respondents who reported using heated tobacco
  said they did not smoke.
  
  However, a paper published this year, led by researchers from Georgetown University, highlighted flaws in the
  government's survey, including changes to the question format
  that can lead to under-reporting of smoking.
  
  Other surveys have also found higher rates of dual use than the government,
  it said.
  
  (Reporting by Emma Rumney; Editing by Matt Scuffham
  and Emelia Sithole-Matarise)
• 
  dust cannon for dust suppression Freitag, 06 Dezember 2024 07:04 Comment Link

  Dust suppression systems are a requirement for
  lots of sectors.
• 
  find ndis service providers Freitag, 06 Dezember 2024 07:04 Comment Link

  USP human development hormone (somatropin).
• 
  sell my business near me Freitag, 06 Dezember 2024 07:04 Comment Link

  That, in return, aids you get a greater asking price.
• 
  learn quantum computing Freitag, 06 Dezember 2024 07:04 Comment Link

  It's an amazing time for quantum computer.
• 
  Bookmarks Freitag, 06 Dezember 2024 07:03 Comment Link

  The plan's average price is 17.4 cents per kWh.
• 
  Bookmarks Freitag, 06 Dezember 2024 07:03 Comment Link

  Region also affects business energy rates.